Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery.
Saved in:
| Title: | Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery. |
|---|---|
| Authors: | Verhoeven RS; 1 Envisia Therapeutics, Durham, North Carolina., Garcia A; 1 Envisia Therapeutics, Durham, North Carolina., Robeson R; 1 Envisia Therapeutics, Durham, North Carolina., Gilger BC; 2 Powered Research , Morrisville, North Carolina., Culp D; 2 Powered Research , Morrisville, North Carolina., Struble C; 3 Covance, Madison, Wisconsin., Hamm L; 4 Intertek Pharmaceutical Services, San Diego, California., Navratil T; 1 Envisia Therapeutics, Durham, North Carolina., Yerxa B; 1 Envisia Therapeutics, Durham, North Carolina. |
| Source: | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2018 Jan/Feb; Vol. 34 (1-2), pp. 161-169. Date of Electronic Publication: 2017 Jun 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Association For Ocular Pharmacology And Therapeutics Country of Publication: United States NLM ID: 9511091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7732 (Electronic) Linking ISSN: 10807683 NLM ISO Abbreviation: J Ocul Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
